Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HCT116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | plasmid | stable transfection | Metafectene | publication | L. Ramapathiran et al., J. Cell Sci., Feb 2014; 127: 609 - 619 | Link | |
HCT116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | plasmid | stable transfection | Metafectene | publication | K. Berger, Georg-August-Universität Göttingen | Link | |
HCT116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | plasmid | Metafectene | publication | J. Pahle et al., BMC Cancer, 2017, 17:129, DOI 10.1186/s12885-017-3123-x | Link | ||
HCT116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | plasmid | stable transfection | Metafectene | publication | U. Sack et al., J Natl Cancer Inst, Jul 2011; 103: 1018 - 1036 | Link | |
HCT116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | plasmid | stable transfection | Metafectene | publication | A.-K. Schmidt et al., bioRxiv preprint, 2021, doi.org/10.1101/2021.10.11.463929 | Link | |
HCT116 p53 -/- |
Human colon adenocarcinoma cell line deficient of p53 | Human | digestive organs | cell line | adherent | plasmid | Metafectene | publication | S. T. Al Rashid et al., Cancer Res., Dec 2005; 65: 10810 - 10821 | Link | |||
HCT15 |
Human colon adenocarcinoma cell line | ATCC CCL-225 | Human | digestive organs | cell line | adherent | plasmid | Metafectene | application note | ![]() |
|||
HEC-1A |
Human endometrial carcinoma cell line | ATCC HTB-112 | Human | genital tract | cell line | adherent | plasmid | Metafectene | publication | H. Kiaris et al., PNAS, Aug 2003; 100: 9512 - 9517 | Link | ||
HEK RXFP1 |
Human embryonic kidney cell line, stably expressing RXFP1 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | M. L. Halls et al., Mol. Pharmacol., Jul 2006; 70: 214 - 226. | Link | |||
HEK RXFP1 |
Human embryonic kidney cell line, stably expressing RXFP1 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | M. L. Halls et al., J. Pharmacol. Exp. Ther., Jan 2007; 320: 281 - 290 | Link | |||
HEK RXFP2 |
Human embryonic kidney cell line, stably expressing RXFP1 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | M. L. Halls et al., Mol. Pharmacol., Jul 2006; 70: 214 - 226. | Link | |||
HEK RXFP2 |
Human embryonic kidney cell line, stably expressing RXFP1 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | M. L. Halls et al., J. Pharmacol. Exp. Ther., Jan 2007; 320: 281 - 290 | Link | |||
HEK-sGC |
Human embryonic kidney cell line, stably expressing human sGC (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | S. Meurer et al., Circ. Res., Jul 2009; 105: 33 - 41 | Link | |||
HEK-TetOn |
Human embryonic kidney cell line stably, expressing the tetracycline transactivators (TetON) | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | F. Steinberg et al., J. Biol. Chem., Nov 2010; 285: 37704 - 37715 | Link | |||
HEK/DOR |
Human embryonic kidney cell line stably expressing DOR (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | D. A. Eisinger et al., Mol. Pharmacol., Feb 2011; 79: 326 - 335 | Link | |||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | M. Ansems et al., J Natl Cancer Inst, Jan 2010; 102: 54 - 68 | Link | ||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | cotransfection (plasmid/siRNA) | Metafectene | publication | M.-J. Stahnke et al., Cellular Signalling, 2014, 26 :1792-1799doi.org/10.1016/j.cellsig.2014.04.006 | ||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | C. Zhu et al., J. Am. Soc. Nephrol., Dec 2016, 27, 3678 - 3689 | |||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene | publication | S. Scherer et al., Dev. Comp. Immunol., 2018, 82 :128-138, doi: 10.1016/j.dci.2018.01.014 | ||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | CRISPR | Metafectene | publication | J. Ohnheiser et al., Biochim. et Biophys. Acta, 2015, 1853: 1564-1573; doi.org/10.1016/j.bbamcr.2015.03.008 | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | A. Schinzel et al., J. Cell Biol., Mar 2004; 164: 1021 - 1032 | Link | ||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | Metafectene | application note | ![]() |
|||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | A. I. Mendes et al., J. Biol. Chem., Dec 2010; 285: 39117 - 39126 | Link | ||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | S. Tinschert et al., Nephrol. Dial. Transplant., Dec 2004; 19: 3150 - 3154 | Link | ||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | CRISPR | Metafectene | publication | A. de Araujo Brasil et al., PNAS, 2019, 116, 51: 25991–26000, doi/10.1073/pnas.1902483116 | Link |